Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Introducing errors in short-lived RNA causes tumors to present antigens on their cell surface, stimulating an immune response.
The five scientists with exceptional promise and novel approaches to fighting cancer have been named the 2021 recipients.
By analyzing the genome of the cells in each stage, researchers were able to identify what changes drive the progression of leukemia.
A new technique called CopyKAT can identify genetic abnormalities linked to cancer in a single cell.
Researchers have identified another molecule that may lead to the development of more effective targeted medications.
The theme of this issue is the science underlying advances in cancer care and treatment.
An inside look at five research developments that have the potential to transform the treatment of cancer
Damon Runyon researchers are making an impact through understanding the biology and developing novel treatments.
Scientists studied how a series of stepwise mutations in normal blood cells could trigger the transformation to cancer.
Results revealed vast cellular diversity in both lung tumors and the tissue surrounding the tumor.
Results appear on an easy-to-read strip that is akin to a pregnancy test, without the need for expensive or specialized lab equipment.
Scientists develop a platform to study early-stage lung cancer and to identify potential new treatments.
Some scientists are investigating how the virus enters humans cells, developing more efficient testing and searching for treatments.
Researchers discover that a molecule that helps cancer cells spread is found at higher levels in otherwise healthy people over 60.
Elevated levels of a protein called RUNX2 in human lung tumors predict a worse prognosis.
Grants totaling nearly $3.5 million give early career investigators independence to pursue brave and bold cancer research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.